Although previous studies of AD suggest that the plasma clusterin level indicates the brain amyloid load, a shared pathology between TBI and AD16,25,32–35, few studies have evaluated clusterin expression in the brain and biofluids following TBI. The gene discussed is CLU; the disease is Alzheimer disease.